Determination of the presence of carbapenemase enzymes in carbapenem-resistant Pseudomonas aeruginosa isolates by susceptibility test based algorithm

被引:0
作者
Ocal, Murat [1 ]
Buyukyanbolu, Ecem [1 ]
Karakus, Mehmet [2 ]
Koca, Oznur [1 ]
Tanriverdi, Seren [3 ]
Erdogan, Fatma [4 ]
Comert, Fusun [4 ]
Otlu, Baris [3 ]
Aktas, Elif [1 ]
机构
[1] Univ Hlth Sci, Hamidiye Etfal Training & Res Hosp, Clin Microbiol Lab, Istanbul, Turkiye
[2] Univ Hlth Sci, Hamidiye Fac Med, Dept Med Microbiol, Istanbul, Turkiye
[3] Inonu Univ, Fac Med, Dept Med Microbiol, Malatya, Turkiye
[4] Bulent Ecevit Univ, Fac Med, Dept Med Microbiol, Zonguldak, Turkiye
关键词
P; aeruginosa; Carbapenemase; Algorithm; CIM;
D O I
10.1016/j.diagmicrobio.2024.116495
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: Phenotypic methods have been proposed for the detection of carbapenemase production. These tests can have slower turnaround times. With the sensitivity-based algorithm described by Gill et al. will be possible to detect the carbapenemase. Methods: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) isolates from three hospitals between January 2017 and December 2021 were included. The modified carbapenemase-inactivation-method(mCIM) and two algorithms were used, defined as "primary algorithm, i.e. ceftazidime and cefepime non-susceptible in addition to imipenem or meropenem resistance" and "secondary algorithm, i.e. ceftolozane/tazobactam non-susceptible in addition to imipenem or meropenem resistance". PCR testing was performed on all isolates. Results: 256 CRPA isolates were included in the study. When the primary or secondary algorithm criteria were applied, there were 173 isolates that met one or both of them. Of these, 29 were CIM-positive isolates. Conclusion: In our study, the use of the algorithm reduced the need for CIM testing by 32 %.
引用
收藏
页数:4
相关论文
共 19 条
  • [1] Evaluation of the Carbapenem Inactivation Method for Detection of Carbapenemase-Producing Gram-Negative Bacteria in Comparison with the RAPIDEC CARBA NP
    Aktas, Elif
    Malkocoglu, Gulsah
    Otlu, Baris
    Cicek, Aysegul Copur
    Kulah, Canan
    Comert, Fusun
    Sandalli, Cemal
    Gursoy, Nafia Canan
    Erdemir, Duygu
    Bulut, Mehmet Emin
    [J]. MICROBIAL DRUG RESISTANCE, 2017, 23 (04) : 457 - +
  • [2] Molecular Analysis of Antibiotic Resistance in Carbapenem-Resistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples
    Altan, Gulsah
    Rakici, Erva
    Ozgumus, Osman Birol
    [J]. MIKROBIYOLOJI BULTENI, 2024, 58 (02): : 148 - 170
  • [3] Antonio Oliver, 2023, Clin Microbiol Infect
  • [4] Laboratory Detection of Enterobacteriaceae That Produce Carbapenemases
    Doyle, Diana
    Peirano, Gisele
    Lascols, Christine
    Lloyd, Tracie
    Church, Deirdre L.
    Pitout, Johann D. D.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (12) : 3877 - 3880
  • [5] eucast, ABOUT US
  • [6] Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
    Gill, Christian M.
    Lasko, Maxwell J.
    Asempa, Tomefa E.
    Nicolau, David P.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (06)
  • [7] Gill Christian M, 2022, Open Forum Infect Dis, V9
  • [8] Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
    Hirsch, Elizabeth B.
    Tam, Vincent H.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 441 - 451
  • [9] Hong DJ, 2015, INFECT CHEMOTHER, V47, P81
  • [10] VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey
    Malkocoglu, Guelsah
    Aktas, Elif
    Bayraktar, Banu
    Otlu, Baris
    Bulut, Mehmet Emin
    [J]. MICROBIAL DRUG RESISTANCE, 2017, 23 (03) : 328 - 334